Literature DB >> 8970950

Previously unsuspected cis-acting sequences for DNA replication revealed by characterization of a chimeric heron/duck hepatitis B virus.

K Mueller-Hill1, D D Loeb.   

Abstract

Heron hepatitis B virus (HHBV) is an avian hepadnavirus that is closely related to duck hepatitis B virus (DHBV). To learn more about the mechanism of hepadnavirus replication, we characterized a clone of HHBV that contains a substitution of DHBV sequence from nucleotide coordinates 403 to 1364. This clone, named HDE1, expresses a chimeric pregenomic RNA, a chimeric polymerase (P) protein, and a core (C) protein with a one-amino-acid substitution at its carboxy terminus. We have shown that HDE1 is defective for minus-strand DNA synthesis, resulting in an overall reduction of viral DNA. HDE1 was also defective for plus-strand DNA synthesis, resulting in aberrant ratios of replication intermediates. Genetic complementation assays indicated that HDE1 replication proteins, C and P, are functional for replication and wild-type HHBV proteins do not rescue either defect. These findings indicate that the HDE1 substitution mutation acts primarily in cis. By restoring nucleotides 403 to 902 to the HHBV sequence, we showed that cis-acting sequences for plus-strand DNA synthesis are located in the 5' half of the HDE1 chimeric region. These data indicate the presence of one or more formerly unrecognized cis-acting sequences for DNA synthesis within the chimeric region (nucleotides 403 to 1364). These cis-acting sequences in the middle of the genome might interact directly or indirectly with known cis elements that are located near the ends of the genome. Our findings suggest that a specific higher-order template structure is involved in the mechanism of hepadnavirus DNA replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970950      PMCID: PMC190918     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis.

Authors:  J M Lien; C E Aldrich; W S Mason
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

Review 2.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting.

Authors:  L J Chang; P Pryciak; D Ganem; H E Varmus
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

4.  The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging.

Authors:  H J Schlicht; R Bartenschlager; H Schaller
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation.

Authors:  J M Lien; D J Petcu; C E Aldrich; W S Mason
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

8.  Replication of duck hepatitis B virus in two differentiated human hepatoma cell lines after transfection with cloned viral DNA.

Authors:  R Hirsch; R Colgrove; D Ganem
Journal:  Virology       Date:  1988-11       Impact factor: 3.616

9.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.

Authors:  J S Tuttleman; C Pourcel; J Summers
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

10.  Isolation and characterization of a hepatitis B virus endemic in herons.

Authors:  R Sprengel; E F Kaleta; H Will
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

View more
  9 in total

1.  Mutations that increase in situ priming also decrease circularization for duck hepatitis B virus.

Authors:  D D Loeb; R Tian
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  cis-Acting sequences that contribute to synthesis of minus-strand DNA are not conserved between hepadnaviruses.

Authors:  Megan L Maguire; Daniel D Loeb
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

3.  Base pairing among three cis-acting sequences contributes to template switching during hepadnavirus reverse transcription.

Authors:  Ning Liu; Ru Tian; Daniel D Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

4.  cis-Acting sequences in addition to donor and acceptor sites are required for template switching during synthesis of plus-strand DNA for duck hepatitis B virus.

Authors:  M B Havert; D D Loeb
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Base pairing between cis-acting sequences contributes to template switching during plus-strand DNA synthesis in human hepatitis B virus.

Authors:  Eric B Lewellyn; Daniel D Loeb
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

6.  Analysis of duck hepatitis B virus reverse transcription indicates a common mechanism for the two template switches during plus-strand DNA synthesis.

Authors:  Michael B Havert; Lin Ji; Daniel D Loeb
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  cis-Acting sequences 5E, M, and 3E interact to contribute to primer translocation and circularization during reverse transcription of avian hepadnavirus DNA.

Authors:  Karlyn Mueller-Hill; Daniel D Loeb
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Changing the site of initiation of plus-strand DNA synthesis inhibits the subsequent template switch during replication of a hepadnavirus.

Authors:  D D Loeb; R Tian; K J Gulya; A E Qualey
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Characterization of the cis-acting contributions to avian hepadnavirus RNA encapsidation.

Authors:  Kristin M Ostrow; Daniel D Loeb
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.